Literature DB >> 3259164

Studies on the synergy between collagen and adjuvant arthritis in rats.

S Q DeJoy1, K M Ferguson, A L Oronsky, S S Kerwar.   

Abstract

Intravenous administration of subarthritogenic doses of anticollagen IgG and adjuvant-sensitized spleen cells to syngeneic naive rats induces an erosive arthritis in recipients. The onset of the clinical disease in recipients is rapid and the disease is severe when compared to those recipients receiving cells alone. Immunocytochemical analysis of the knee synovium indicates the accumulation in the adipose tissue of Ia+ (ED1+)macrophages, OX-19+ T lymphocytes, and neutrophils. A large proportion of the lining cells of the proliferative synovium are Ia+. The knee synovium is extremely edematous and contains fibrin. If recipient rats are decomplemented, clinical disease is delayed and the number of mononuclear and polymorphonuclear cells accumulating in the synovium is decreased. Similar results are observed if recipient rats are treated with anti-Ia+ antibody. However, anti-Ia+ treatment does not induce depletion of serum complement.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259164     DOI: 10.1016/0008-8749(88)90011-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1.

Authors:  Y Tada; A Ho; T Matsuyama; T W Mak
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

2.  Cell migration studies in the adoptive transfer of adjuvant arthritis in the Lewis rat.

Authors:  A G Van de Langerijt; S G Volsen; C A Hicks; P J Craig; M E Billingham; W B Van den Berg
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

3.  Streptococcal cell wall arthritis. Passive transfer of disease with a T cell line and crossreactivity of streptococcal cell wall antigens with Mycobacterium tuberculosis.

Authors:  S Q DeJoy; K M Ferguson; T M Sapp; J B Zabriskie; A L Oronsky; S S Kerwar
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.